UA105759C2 - 2,4-діамінопіримідини, фармацевтична композиція, що їх містить, та спосіб лікування малярії - Google Patents

2,4-діамінопіримідини, фармацевтична композиція, що їх містить, та спосіб лікування малярії

Info

Publication number
UA105759C2
UA105759C2 UAA201004117A UAA201004117A UA105759C2 UA 105759 C2 UA105759 C2 UA 105759C2 UA A201004117 A UAA201004117 A UA A201004117A UA A201004117 A UAA201004117 A UA A201004117A UA 105759 C2 UA105759 C2 UA 105759C2
Authority
UA
Ukraine
Prior art keywords
malaria
treatment
diaminopyrimidines
pharmaceutical composition
compounds
Prior art date
Application number
UAA201004117A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Бонгкоч Тарнчомпу
Йонгіют Ютхавонг
Тірают Вілаїван
Пенчіт Чітнумсуб
Чавані Тонгпанчанг
Сумалі Камчонвонгпайсан
Дейвід Меттьюз
Лівія Вівас
Джірундон Юваніяма
Сьюзан ЧАРМАН
Уільям Чарман
Санджай Бабу Катіяр
Original Assignee
Ммв Медісінс Фор Мелеріе Венче
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ммв Медісінс Фор Мелеріе Венче filed Critical Ммв Медісінс Фор Мелеріе Венче
Publication of UA105759C2 publication Critical patent/UA105759C2/uk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UAA201004117A 2007-10-08 2008-10-08 2,4-діамінопіримідини, фармацевтична композиція, що їх містить, та спосіб лікування малярії UA105759C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97837507P 2007-10-08 2007-10-08
PCT/US2008/079210 WO2009048957A1 (en) 2007-10-08 2008-10-08 Antimalarial compounds with flexible side-chains

Publications (1)

Publication Number Publication Date
UA105759C2 true UA105759C2 (uk) 2014-06-25

Family

ID=40534843

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201004117A UA105759C2 (uk) 2007-10-08 2008-10-08 2,4-діамінопіримідини, фармацевтична композиція, що їх містить, та спосіб лікування малярії

Country Status (22)

Country Link
US (1) US8530491B2 (enExample)
EP (2) EP3546452A1 (enExample)
JP (1) JP5603775B2 (enExample)
KR (1) KR101578949B1 (enExample)
CN (1) CN101820879B (enExample)
AU (1) AU2008310898B2 (enExample)
BR (1) BRPI0818618B8 (enExample)
CA (1) CA2700880C (enExample)
CY (1) CY1121598T1 (enExample)
DK (1) DK2194985T3 (enExample)
ES (1) ES2727015T3 (enExample)
HR (1) HRP20190589T1 (enExample)
HU (1) HUE044398T2 (enExample)
LT (1) LT2194985T (enExample)
MX (1) MX2010003739A (enExample)
PL (1) PL2194985T3 (enExample)
PT (1) PT2194985T (enExample)
RU (1) RU2485107C2 (enExample)
SI (1) SI2194985T1 (enExample)
TR (1) TR201904913T4 (enExample)
UA (1) UA105759C2 (enExample)
WO (1) WO2009048957A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012108845A1 (en) * 2011-02-09 2012-08-16 National Science And Technology Development Agency A bacterial surrogate for testing of antimalarials: thya knockout and fola knockout bacteria for testing of inhibition of malarial dihydrofolate reductase-thymidylate synthase
US9000003B2 (en) * 2011-03-10 2015-04-07 National Science And Technology Development Agency Anti-folate antimalarials with dual-binding modes and their preparation
WO2015047199A2 (en) 2013-09-30 2015-04-02 National Science And Technology Development Agency A bacterial surrogate for testing of antimalarials: thya knockout, fola knockout, folp knockout, and folk knockout bacteria for testing of inhibition of antifolate pathway
CN104593406A (zh) * 2015-01-08 2015-05-06 山西医科大学 pIRES/TgDHFR-TS真核表达重组质粒及其构建和应用
WO2017052479A1 (en) * 2015-09-23 2017-03-30 National Science And Technology Development Agency 2,4-diamino-6-ethylpyrimidine derivatives with antimalarial activities against plasmodium falciparum
CN106083742A (zh) * 2016-05-31 2016-11-09 广东工业大学 一种2,4‑二胺基喹唑啉衍生物及其制备方法和应用
WO2021155748A1 (en) * 2020-02-04 2021-08-12 Tsinghua University Inhibitors of malarial and plasmodium falciparum hexose transporter and uses thereof
CN112961106A (zh) * 2021-03-13 2021-06-15 德州学院 一种4-羟基-6氯喹啉合成新工艺
EP4438596A1 (en) * 2023-03-28 2024-10-02 Université de Lille Diaminopyrimidine derivatives as hdac and dhfr dual-targeting inhibitors and use thereof in preventing and treating malaria
WO2025053796A1 (en) * 2023-09-04 2025-03-13 National Science And Technology Development Agency Hybrid molecules between pyrimidine derivatives and idasanutlin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
GB1546937A (en) * 1976-07-29 1979-05-31 Beecham Group Ltd 2,4-diaminopyrimidine derivatives
FR2397407A2 (fr) * 1977-07-11 1979-02-09 Dick Pierre Derives de 2,4-diamino pyrimidines et leur mise en solution en association avec des sulfamides
OA07362A (fr) * 1980-10-27 1984-06-30 May & Baker Ltd Dérivés de la pyrimidine, leur procédé de préparation et les compositions les contenant.
GB2086386B (en) 1980-10-27 1984-01-18 May & Baker Ltd Pyrimidine derivatives
US5322858A (en) 1992-02-14 1994-06-21 Jacobus Pharmaceutical Co. Inc. N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
RU95113597A (ru) 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
HK1042049A1 (en) 1999-05-24 2002-08-02 Sankyo Company, Limited Medicinal compositions containing anti-fas antibody
IT1317826B1 (it) * 2000-02-11 2003-07-15 Dompe Spa Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8.
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them

Also Published As

Publication number Publication date
TR201904913T4 (tr) 2019-05-21
JP5603775B2 (ja) 2014-10-08
WO2009048957A1 (en) 2009-04-16
CY1121598T1 (el) 2020-07-31
WO2009048957A8 (en) 2010-04-22
RU2485107C2 (ru) 2013-06-20
ES2727015T3 (es) 2019-10-11
EP2194985A1 (en) 2010-06-16
HUE044398T2 (hu) 2019-10-28
CA2700880A1 (en) 2009-04-16
AU2008310898A1 (en) 2009-04-16
PL2194985T3 (pl) 2019-12-31
EP2194985A4 (en) 2012-01-25
BRPI0818618A2 (pt) 2015-08-04
KR101578949B1 (ko) 2015-12-18
JP2010540666A (ja) 2010-12-24
SI2194985T1 (sl) 2019-04-30
CA2700880C (en) 2016-03-08
LT2194985T (lt) 2019-04-10
PT2194985T (pt) 2019-05-30
RU2010117193A (ru) 2011-11-20
EP3546452A1 (en) 2019-10-02
US20090099220A1 (en) 2009-04-16
MX2010003739A (es) 2010-04-21
CN101820879A (zh) 2010-09-01
BRPI0818618B1 (pt) 2020-03-03
AU2008310898B2 (en) 2014-05-08
HRP20190589T1 (hr) 2019-05-31
KR20100094459A (ko) 2010-08-26
EP2194985B1 (en) 2019-02-20
DK2194985T3 (da) 2019-05-20
US8530491B2 (en) 2013-09-10
CN101820879B (zh) 2013-01-02
BRPI0818618B8 (pt) 2023-04-25

Similar Documents

Publication Publication Date Title
UA105759C2 (uk) 2,4-діамінопіримідини, фармацевтична композиція, що їх містить, та спосіб лікування малярії
MX2008012576A (es) Pirimidinas 5-amido sustituidas inhibidoras del virus de inmunodeficiencia humana.
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
MXPA05008867A (es) Pirimidinas y triazinas inhibidoras de la replicacion del virus de inmunodeficiencia humana.
WO2008094737A3 (en) Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
GEP20156239B (en) Benzofuranyl derivatives used as glucokinase inhibitors
MY152021A (en) Spiro-indole derivatives for the treatment of parasitic diseases
EP2842559A3 (en) Compounds, compositions and methods for the treatment of viral infections and other medical disorders
GEP20125701B (en) Application of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
WO2010079431A3 (en) Compounds for the prevention and treatment of cardiovascular disease
MX2009005881A (es) Derivados de 2-(piperidin-4-il)-4-fenoxi o fenilamino-pirimidina como inhibidores de la transcriptasa inversa no nucleosida.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
WO2007100614A3 (en) STABLE NON-CRYSTALLINE FORMULATION COMPRISING HMG-CoA REDUCTASE INHIBITOR
IL193252A0 (en) N-hydroxyacrylamide compounds
MY151005A (en) Amide compounds as boosters of antivirals
WO2007119601A3 (en) Nanoparticles comprising a pdgf receptor tyrosine kinase inhibitor
ATE530188T1 (de) Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs
CY1114377T1 (el) 5-(3,4-διχλωρο-φαινυλο)-ν-(2-υδροξυ-κυκλοεξυλο)-6-(2,2,2-τριφθορο-αιθοξυ)-νικοτιναμιδιο και αλατα αυτου ως παραγοντες που αυξανουν την hdl χοληστερολη
DK1750703T3 (da) Fremgangsmåde til at reducere gastrointestinal toksitet forårsaget af indgivelsen af tegafur
WO2010023473A3 (en) Crystalline form of sunitinib and processes for its preparation
MY193080A (en) Crystalline forms
WO2006088541A3 (en) Quinoline derivatives and uses thereof
JO2820B1 (en) Combination of refined thiazolium salt or a primary compound and artemisinin or a derivative thereof to treat serious malaria cases
WO2010068920A3 (en) Diaminoquinazoline inhibitors of dihydrofolate reductase
MX2008001838A (es) Sales y polimorfos de un inhibidor de vegf-r.